May A. El‐Manawaty
- Organic Chemistry top 5%
- Synthesis and biological activity 20
- Synthesis and Characterization of Heterocyclic Compounds 6
- Synthesis and Biological Evaluation 6
- Click Chemistry and Applications 5
- Drug Discovery top 10%
- Toxicology top 5%
- Molecular Medicine top 10%
- Parasitology top 10%
-
- Cancer therapeutics and mechanisms 5
-
- Natural Antidiabetic Agents Studies 4
-
- Phytochemistry and Bioactivity Studies 3
-
- Nanoparticle-Based Drug Delivery 3
- Co-authors
- Walid FayadSalwa M. El‐HalloutyKhaled MahmoudEman S. NossierB. El-MenshawiHeba S. A. ElzahabiAdel S. GirgisStig Linder
- Journals
- Scientific Reports (3 papers)Journal of Enzyme Inhibition and Medicinal Chemistry (2 papers)Bioorganic Chemistry (2 papers)
- Partner nations
- EgyptSaudi ArabiaUnited States
In The Last Decade
May A. El‐Manawaty
42 papers receiving 731 citations
Peers
Comparison fields: 5 of 82
- Organic Chemistry 386
- Drug Discovery 2
- Toxicology 35
- Molecular Medicine 42
- Parasitology 33
Countries citing papers authored by May A. El‐Manawaty
This map shows the geographic impact of May A. El‐Manawaty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May A. El‐Manawaty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May A. El‐Manawaty more than expected).
Fields of papers citing papers by May A. El‐Manawaty
This network shows the impact of papers produced by May A. El‐Manawaty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May A. El‐Manawaty. The network helps show where May A. El‐Manawaty may publish in the future.
Co-authorship network
The 25 scholars most cited alongside May A. El‐Manawaty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 7 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 8 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 30 | |
| 8 | 2022 | 18 | |
| 9 | 2021 | 6 | |
| 10 | 2021 | 25 | |
| 11 | 2021 | 35 | |
| 12 | 2020 | 39 | |
| 13 | 2019 | 25 | |
| 14 | 2019 | 19 | |
| 15 | 2019 | 17 | |
| 16 | 2019 | 7 | |
| 17 | 2018 | 55 | |
| 18 | 2018 | 9 | |
| 19 | 2016 | 23 | |
| 20 | 2011 | 29 |
About May A. El‐Manawaty
May A. El‐Manawaty is a scholar working on Organic Chemistry, Molecular Medicine and Toxicology, having authored 43 papers that have together received 741 indexed citations. Recurring topics across this work include Synthesis and biological activity (20 papers), Synthesis and Characterization of Heterocyclic Compounds (6 papers), Synthesis and Biological Evaluation (6 papers), Cancer therapeutics and mechanisms (5 papers), Click Chemistry and Applications (5 papers), Natural Antidiabetic Agents Studies (4 papers), Phytochemistry and Bioactivity Studies (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). The work is most often cited by research in Organic Chemistry (386 citations), Drug Discovery (2 citations) and Toxicology (35 citations). May A. El‐Manawaty has collaborated with scholars based in Egypt, Saudi Arabia and United States. Frequent co-authors include Walid Fayad, Salwa M. El‐Hallouty, Khaled Mahmoud, Eman S. Nossier, B. El-Menshawi, Heba S. A. Elzahabi, Adel S. Girgis, Stig Linder, Maria Hägg Olofsson and Siva S. Panda. Their work appears in journals such as Scientific Reports, Journal of Enzyme Inhibition and Medicinal Chemistry, Bioorganic Chemistry, Biosensors and Pharmaceutical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.